High Glucose Abnormalities and Its Risk Factors in Adult Patients Attending Outpatient Clinics in Banjul, the Gambia
[1]
Bernard C. Nkum, Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
[2]
Frank B. Micah, Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
[3]
Theophilus C. Ankrah, Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
[4]
Ousman Nyan, Department of Medicine, Edward Francis Small Teaching Hospital, Banjul, The Gambia; Medical Research Council Laboratories, Fajara, The Gambia.
[5]
A. E. Ohwovoriole, Department of Medicine, College of Medicine of the University of Lagos, Lagos, Nigeria.
Background: By virtue of its potency as a risk factor and prognostic importance, the presence of an abnormal glucose tolerance in a patient deserves serious attention and makes its diagnosis a priority. Objective: To determine the prevalence of previously undiagnosed diabetes mellitus (PUDM), impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) among patients attending clinics in Banjul, The Gambia and determine the risk factors associated with these states of abnormal glucose tolerance. Design: Cross-sectional study. Setting: Outpatient clinics of Royal Edward Francis Small Teaching Hospital and Medical Research Council Laboratories in Banjul. Methods: Two hundred and eight consecutive patients with hypertension on treatment and 108 non-hypertensive patients aged over 25years were enrolled. A questionnaire was filled and anthropometric measurements were taken. The standard oral glucose tolerance test (OGTT) was done. The WHO glucometabolic criteria was used in classifying the participants as normal OGTT, PUDM, IFG and IGT. Results: The mean (±SD) of blood glucose at 0min (FBG) was 5.7 (± 2.4) mmol/l while the mean (± SD) blood glucose at 120min (2HBG) was 7.7 (±2.2) mmol/l. Eighty percent had FBG of < 6.1mmol/l, 10% had FBG ≥6.1 - < 7.0mmol/l while another 10% had ≥ 7.0mmol/l. Sixty percent of participants had 2HBG < 7.8mmol/L, 32% had ≥ 7.8 - < 11.1 mmol/l and the remaining 8% ≥ 11.1mmol/l. Fifty-three percent had a normal OGTT, 4% had IFG, 29% had IGT and 15% had PUDM from the OGTT using the WHO criteria. PUDM and IGT were associated with hypertension but IFG was not associated with any of the risk factors. Conclusion: The prevalence of PUDM, IFG and IGT in patients attending clinics in Banjul was high. The major risk factor for PUDM and IGT was hypertension.
Systemic Hypertension, Impaired Fasting Glucose, Impaired Glucose Tolerance, Diabetes Mellitus, Oral Glucose Tolerance Test
[1]
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998 Jul;15(7):539-53.
[2]
World Health Organisation. Definition and diagnosis diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF Consultation, Geneva, Switzerland. 2006.
[3]
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B; American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar;30(3):753-9.
[4]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006 Jan;29 Suppl 1:S43-8.
[5]
Cook AR. Notes on the diseases met with in Uganda, central Africa. J Trop Med 1901 ; 4: 175-178.
[6]
International Diabetes Federaton atlas. Available at http://www.diabetesatlas.org/contact and accessed on 3rd October, 2010.
[7]
van der Sande MA, Bailey R, Faal H, Banya WA, Dolin P, Nyan OA et al. Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health. 1997 Nov;2(11):1039-48.
[8]
van der Sande MA, Walraven GE, Milligan PJ, Banya WA, Ceesay SM, Nyan OA et al. Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bull World Health Organ. 2001;79(4):321-8.
[9]
van der Sande MA, Ceesay SM, Milligan PJ, Nyan OA, Banya WA, Prentice A et al. Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities. Am J Public Health. 2001 Oct;91(10):1641-4.
[10]
van der Sande MA, Milligan PJ, Nyan OA, Rowley JT, Banya WA, Ceesay SM et al. Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens. 2000 Aug;14(8):489-96.
[11]
van der Sande MA, Walraven GE, Bailey R, Rowley JT, Banya WA, Nyan OA et al. Is there a role for glycosuria testing in sub-Saharan Africa? Trop Med Int Health. 1999 Jul;4(7):506-13.
[12]
van der Sande MA, Milligan PJ, Walraven GE, Dolmans WM, Newport M, Nyan OA et al. Geographical variation in prevalence of hypertension within The Gambia. J Hum Hypertens. 2001 Oct;15(10):733-9.
[13]
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343-50.
[14]
Nkum BC, Nyan O, Corrah T, Ankrah TC, Allen S, Micah FB., et al. Resting electrocardiographic and echocardiographic findings in an urban community in the Gambia. Journal of Science and Technology. 2009; 29:130-140.
[15]
Nkum BC, Micah FB, Ankrah TC Nyan O. Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study. PLoS One. 2014 Apr 4;9(4):e93606.
[16]
Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS., et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986; 7: 639-650.
[17]
Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. Br Med J. 1994; 308:1011-1014.
[18]
World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. 1999.
[19]
Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):1009-60.
[20]
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.Obes Res. 1998 Sep;6 Suppl 2:51S-209S.
[21]
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005 Sep 24-30;366(9491):1059-62.
[22]
Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza J et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care. 2006 Aug;29(8):1866-71.
[23]
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000 Mar 30;342(13):905-12.
[24]
Amoah AG. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol. 2002 Apr;39(1):7-13.
[25]
Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002 Jun;56(3):197-205.
[26]
Sabir AA, Isezuo SA, Ohwovoriole AE. Dysglycaemia and its risk factors in an urban fulani population of northern Nigeria. West Afr J Med. 2011 Sep-Oct;30(5):325-30.
[27]
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998 Apr;21(4):518-24.
[28]
Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006 Jun;29(6):1263-8.
[29]
Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010 Nov;33(11):2355-9.
[30]
Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002 May;25(5):829-34.
